Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

3Brain AG

History from 12 May 2016

UID
CHE-387.460.635
Legal form
AG
Canton
SZ
Founded
not in the record
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 191k
48k95k143k191k14 Dec 2018 · CHF 106k28 Aug 2019 · CHF 111k18 Aug 2022 · CHF 150k3 Jun 2026 · CHF 191k20192020202120222023202420252026
  • shares

Record

  1. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    100’000 → 105’968.10
    Shares
    2’000’000 → 2’119’362
    New shares, % of post-step shares
    5.6% (119’362 new)

    Aktienkapital neu: CHF 105'968.10 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 105'968.10 [bisher: CHF 100'000.00]. Aktien neu: 2'119'362 Namenaktien zu CHF 0.05 [bisher: 2'000'000 Namenaktien zu CHF 0.05]. Kapitalerhöhung aus genehmigtem Aktienkapital.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1004520700 ↗
  2. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    105’968.10 → 111’168.10
    Shares
    2’119’362 → 2’223’362
    New shares, % of post-step shares
    4.7% (104’000 new)

    Aktienkapital neu: CHF 111'168.10 [bisher: CHF 105'968.10]. Liberierung Aktienkapital neu: CHF 111'168.10 [bisher: CHF 105'968.10]. Aktien neu: 2'223'362 Namenaktien zu CHF 0.05 [bisher: 2'119'362 Namenaktien zu CHF 0.05]. Kapitalerhöhung aus genehmigtem Aktienkapital.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1004703781 ↗
  3. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    111’168.10 → 150’000
    Shares
    2’223’362 → 3’000’000
    New shares, % of post-step shares
    25.9% (776’638 new)

    Aktienkapital neu: CHF 150'000.00 [bisher: CHF 111'168.10]. Liberierung Aktienkapital neu: CHF 150'000.00 [bisher: CHF 111'168.10]. Aktien neu: 3'000'000 Namenaktien zu CHF 0.05 [bisher: 2'223'362 Namenaktien zu CHF 0.05].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1005543071 ↗
  4. Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    150’000 → 190’750
    Shares
    3’000’000 → 3’815’000
    New shares, % of post-step shares
    21.4% (815’000 new)

    Aktienkapital neu: CHF 190'750.00 [bisher: CHF 150'000.00]. Liberierung Aktienkapital neu: CHF 190'750.00 [bisher: CHF 150'000.00]. Aktien neu: 3'815'000 Namenaktien zu CHF 0.05 [bisher: 3'000'000 Namenaktien zu CHF 0.05]. [gestrichen: Die Gesellschaft hat mit Beschluss vom 08.06.2020 eine genehmigte Kapitalerhöhung gemäss näherer Umschreibung in den Statuten beschlossen.]. Ordentliche Kapitalerhöhung.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.82 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006665827 ↗

Published by 8 Oct 2026